Status:
COMPLETED
An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Dementia Alzheimers
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study will be to design, implement and test the impact of a quality improvement (QI) intervention that uses an EHR CDS tool among physicians newly ordering an antipsychotic medication...
Detailed Description
Importance: Among patients with Alzheimer's disease and its related dementias (ADRD) with behavioral disturbances, antipsychotic prescriptions have limited efficacy and substantially increase risk of ...
Eligibility Criteria
Inclusion
- Physicians who will be eligible to receive the EHR CDS tool intervention include those who provide ambulatory care in the UCLA health system and have newly prescribed antipsychotics (e.g., Quetiepine, Olanzapine, Risperidone, Aripiprazole, Haloperidol, Clozapine) for eligible patients (described below) at the medical center in the last 24 months.
- Eligible patients will be enrolled in the study during their first encounter with one of the randomized physicians (see above) during which a new antipsychotic medication order will be initiated. Inclusion criteria for patients will include: 1) having an assigned primary care physician (PCP) and/or assignment to an Accountable Care Organization (ACO) at UCLA Health, and: 2) being part of the health system's EHR-based dementia registry.
Exclusion
- Patients who have diagnosis codes for schizophrenic disorders, delusion disorders, bipolar disorders, or other non-organic psychoses on their problem list.
- Patients with Parkinson's disease on their problem list
- Patients who have been prescribed antipsychotics in the prior 12 months
Key Trial Info
Start Date :
August 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2023
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT04851691
Start Date
August 3 2021
End Date
August 14 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Health
Los Angeles, California, United States, 90095